Dissection of gammaretroviral receptor function by using type III phosphate transporters as models.
Gammaretroviruses that enter cells via binding to a surface receptor use one of two fundamental mechanisms. In the first, binding of the virus particle to its cognate receptor is followed by fusion and internalization. The second, less common mechanism requires the addition of an accessory protein in order to achieve fusion and entry into the target cells; this protein is usually the soluble form of the envelope protein containing the receptor-binding domain (RBD). For some viruses, such as amphotropic murine leukemia virus (A-MLV), particles with fusion-defective envelope proteins can enter cells in the presence of their own RBD or that of another viral envelope, regardless of its cognate receptor, suggesting that these viruses share a common entry mechanism. A notable exception is gibbon ape leukemia virus (GALV). Fusion-impaired GALV envelope mutants can be trans-activated for infectivity only by GALV RBDs. Using dually functional GALV/A-MLV receptors, we examined the role of receptor with respect to which RBD could overcome fusion impaired virus entry.
National Institute of Mental Health, Laboratory of Cellular and Molecular Biology, Section on Molecular Virology, Building 49, Room 5A32, 49 Convent Dr., MSC 4483, Bethesda, MD 20892, USA.
Karen B
KB
Farrell
Maribeth V
MV
Eiden
D000818:Animals; D017989:Leukemia Virus, Gibbon Ape / Q000502:physiology*; D008561:Membrane Fusion; D051379:Mice; D011991:Receptors, Virus / Q000502:physiology*; D050608:Sodium-Phosphate Cotransporter Proteins; D027981:Symporters / Q000502:physiology*
D011991:Receptors, Virus; D050608:Sodium-Phosphate Cotransporter Proteins; D027981:Symporters